Cipla | CIPLA - Stammkapital

Aktienkurs
1,256.40
Täglich Wechseln
17.20 1.39%
Monatlich
-5.28%
Jährlich
-17.55%
Q1 Prognose
1,230.90




Stammkapital Veränderung Datum
Arca Biopharma USD 48.72M 338K 2025-12
aTyr Pharma USD 16.65M 81.34M 2025-12
Bio Path USD 9.24M 934K 2025-09
Brainstorm Cell Therapeutics USD 11.03M 913K 2025-09
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cara Therapeutics USD 2K 3K 2025-03
Cipla INR 807.77M 807.43M 2025-09
Dr.Reddys Laboratories INR 832.52M 144K 2025-09
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Immunic USD 8K 4K 2024-06
Infinity Pharmaceuticals USD 90K 1000 2023-06
Minerva Neurosciences USD 1000 0 2024-09
Nektar Therapeutics USD 19K 0 2024-09
Sun Pharmaceuticals INR 2.4B 35K 2025-09
TherapeuticsMD USD 11K 0 2023-09
UPL INR 843.31M 746.69M 2025-09